280 related articles for article (PubMed ID: 8884811)
21. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
23. Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines.
Oka H; Ikeda K; Yoshimura H; Ohuchida A; Honma M
Mutat Res; 2006 Jul; 606(1-2):52-60. PubMed ID: 16584912
[TBL] [Abstract][Full Text] [Related]
24. [Activities of enzymes converting 5-fluorouracil to 5-fluorouridine-5' monophosphate and 5-fluorodeoxyuridine-5' monophosphate in subcultured cell lines and solid tumor tissues].
Uchida M; Kamiya K; Yoshimura T; Sasaki K; Tsutani H; Nakamura T; Ho DH
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):990-6. PubMed ID: 2167917
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil.
Patel M; Ardalan K; Hochman I; Tian EM; Ardalan B
Anticancer Res; 2003; 23(1A):447-52. PubMed ID: 12680247
[TBL] [Abstract][Full Text] [Related]
26. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
27. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
Fischel JL; Etienne MC; Spector T; Formento P; Renée N; Milano G
Clin Cancer Res; 1995 Sep; 1(9):991-6. PubMed ID: 9816071
[TBL] [Abstract][Full Text] [Related]
28. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
29. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
30. Resistance of colorectal cancer cells to 5-FUdR and 5-FU caused by Mycoplasma infection.
Jetté L; Bissoon-Haqqani S; Le François B; Maroun JA; Birnboim HC
Anticancer Res; 2008; 28(4B):2175-80. PubMed ID: 18751392
[TBL] [Abstract][Full Text] [Related]
31. Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts.
Taverna P; Rendahl K; Jekic-McMullen D; Shao Y; Aardalen K; Salangsang F; Doyle L; Moler E; Hibner B
Biochem Pharmacol; 2007 Jan; 73(1):44-55. PubMed ID: 17046720
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ
Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807
[TBL] [Abstract][Full Text] [Related]
33. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
34. Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens.
Katsumata K; Tomioka H; Sumi T; Yamashita S; Takagi M; Kato F; Nakamura R; Koyanagi Y; Aoki T; Kato K
Cancer Chemother Pharmacol; 2003 Feb; 51(2):155-60. PubMed ID: 12647017
[TBL] [Abstract][Full Text] [Related]
35. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.
Blomgren H; Edler D; Hallström M; Ragnhammar P
Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376
[TBL] [Abstract][Full Text] [Related]
36. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of 5-fluorouracil sensitivity by an rTS signaling mimic in H630 colon cancer cells.
Dolnick R; Wu Q; Angelino NJ; Stephanie LV; Chow KC; Sufrin JR; Dolnick BJ
Cancer Res; 2005 Jul; 65(13):5917-24. PubMed ID: 15994970
[TBL] [Abstract][Full Text] [Related]
38. Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA.
Chu E; Lai GM; Zinn S; Allegra CJ
Mol Pharmacol; 1990 Sep; 38(3):410-7. PubMed ID: 2402230
[TBL] [Abstract][Full Text] [Related]
39. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
[TBL] [Abstract][Full Text] [Related]
40. [The correlation between thymidylate synthase expression and cytotoxicity of 5-fluorouracil in human cancer cell lines: study using polyclonal antibody against recombinant human thymidylate synthase].
Okabe H; Tsujimoto H; Fukushima M
Gan To Kagaku Ryoho; 1997 Apr; 24(6):705-12. PubMed ID: 9126308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
